Clonazepam-BSA Antigen

Designed for immunoassay development and supplied through Antibodies.com, this synthetic Clonazepam-BSA Antigen is presented as a liquid antigen-BSA conjugate intended for ELISA workflows. The reagent is supplied at 1 mg per vial and is formulated in distilled water as an Antigen-BSA conjugate, with the clonazepam hapten chemically coupled to bovine serum albumin to enable reproducible coating of microtiter plates. As a small-molecule hapten-protein conjugate, it does not carry a host species, clonality, or isotype designation; rather, its reactivity is directed against the clonazepam molecule, making it suitable as a coating antigen or competitive binder in immunoassays that screen for this long-acting benzodiazepine. Short-term storage at 2–8 °C is recommended for periods of up to two weeks, while long-term stability is maintained at –20 °C, and repeated freeze/thaw cycles should be avoided to preserve conjugate integrity. The product is shipped on cold packs from St. Louis, MO, and is intended for research use only, not for diagnostic or therapeutic applications. When paired with an appropriate anti-clonazepam antibody, this conjugate supports the development of robust quantitative ELISA methods for clonazepam detection in research settings.